The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation. [electronic resource]
Producer: 20081016Description: 3073-81 p. digitalISSN:- 1528-0020
- Adolescent
- Adult
- Child
- Child, Preschool
- Etanercept
- Female
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Humans
- Immunoglobulin G -- administration & dosage
- Immunosuppressive Agents -- therapeutic use
- Infant
- Inflammation
- Male
- Middle Aged
- Pneumonia -- drug therapy
- Receptors, Tumor Necrosis Factor -- administration & dosage
- Syndrome
- Transplantation, Homologous -- adverse effects
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.